.
Electronic pupillography enables one to detect subtle degrees of pupillary abnormalities as well as to quantify pupillary responses. Pupillographic investigations have recently been improved both by using a well-controlled stimulus (open-loop stimulus) and by examining the derivative curves (velocity and acceleration) of pupillary responses (Meyer, Ogle, Hollenhorst, and Moyer, I969; Morgan, Hollenhorst, and Ogle, 1968) . By focusing the stimulus light, the diameter of the light ray can be made smaller than the smallest size of the pupil (Maxwellian view). Hence, pupillary responses (changes in the size of the iris aperture) will not affect the stimulus. This is called an open-loop stimulus and enables one to control the stimulus precisely.
We have investigated pupillary responses in patients with myasthenia gravis and in normal controls both before and after edrophonium chloride injections. By using an open-loop stimulus and measuring the derivative curves of pupillary reaction with infrared video pupillography (Ishikawa, Naito, and Inaba, I970), involvement of pupillary responses in most of our patients was demonstrated.
Methods and materials PATIENTS AND CONTROL SUBJECTS
Seven patients ranging from i2 to 45 years of age with myasthenia gravis were examined. Six had ocular myasthenia gravis, and one had generalized myasthenia gravis. In each patient, the diagnosis was established by a typical history and physical findings of muscular weakness and fatigue. The diagnosis was confirmed electromyographically by a decline in the amplitude of the action potential and by showing improvement in muscle strength after injection of io mg intravenous edrophonium chloride either from skeletal muscle or from extraocular muscle.
In Table I the clinical data are summarized. Only two patients (nos 5 and 6) had been treated with oral anticholinesterase in the past, but none was taking anticholinesterase medication at the time of the examination. The same two patients had been treated with oral prednisolone on alternate days. One patient (no. 5) had had a poor response to prednisolone and therefore it had been withdrawn about one week before measurement of his pupillary response. The other patient responded well to prednisolone and was taking medication at the time of examination (prednisolone IOO mg/ day). Five healthy adults were selected for controls with a mean age of 25 years; three of them were given edrophonium injections.
RECORDING OF THE PUPILLARY LIGHT RESPONSE
The pupillary light response curve was recorded using electronic infrared video pupillography (Ishikawa and others, 1970) . This system consisted of an infraredsensitive silicon-vidicon camera (HTV-N-248), a video analysing system with specially designed integrated circuits for calculating the pupillary area, and a monitor scope. Responses were linearly related to pupillary area within ±i per cent in the range of O-OI mm2 and I50 mm2. System sampling rate was 6o Hz.
Both sinusoidal (o25 to 30o Hz) and pulse (one second) stimuli were used. The stimuli were presented under open-loop condition. The light source was a helium neon gas laser with 6328 A wave length and o-8 mm beam diameter, which was less than the smallest diameter of the pupil. The one-second pulse stimulus of o0o5 mW (about five log units above visual threshold) was delivered through a shutter of five-second intervals.
The sinusoidal stimulus of zero to 0o0075 mW with varied frequencies of 0o25 to 30o Hz was produced by using a neutral density filter, a stationary polaroid filter, and a rotating polaroid filter in the beam path.
Each subject was seated in front of the pupillograph vidicon camera and the head was steadied with a chin and forehead rest. After I5 minutes' dark adaptation, the subject was asked to fixate a small red light (2 mm in diameter) through a half mirror inserted between the C: maximum change in pupillary arealsteady state of pupillary area, and D: maximum rate of constriction. These are moderately abnormal before edrophonium, approaching nearly normal valte one to two minutes after injection phonium injection, approached nearly normal values by one to two minutes after edrophonium injection (Fig. 4a, b, c, d ). The most striking effect of edrophonium was upon the rate of acceleration of pupillary constriction (Ac) as shown in Fig. 5a . Even one of the treated individuals showed a positive response. Changes in the rate of deceleration of pupillary constriction (Dc) were less than changes in Ac (Fig. 5b) . In contrast, changes in the parameters (MRD, Ad, and Dd) of pupillary dilatation were minimal and only Ad showed a very slight increase with edrophonium administration. In summary, in myasthenic patients edrophonium injections caused marked improvement in the parameters of pupillary constriction (especially Ac) but only minimal changes in the parameters of pupillary dilatation. No response to edrophonium injection was noted in normal subjects.
Discussion
Using electronic pupillography, abnormal pupillary reactions to an open-loop stimulus were observed in a group of patients with myasthenia gravis. Five patients without earlier treatment and one patient with previous corticosteroid therapy showed reduction in the amplitude of pupillary constriction as well as reduced velocity and acceleration in the pupillary light response. The parameters of AP/P, MRC, Tc, Ac, and Ad were abnormal before edrophonium injection and approached nearly normal values after the administration of edrophonium. In contrast, the same dose of edrophonium had no effect upon responses of normal controls. The more severely affected parameters were AP/P, MRC, Tc, and Ac which reflected iris sphincter function. In contrast, the parameters of pupillary dilatation, with the exception of Ad, which may reflect iris sphincter relaxation, were unaffected by edrophonium injection. Therefore, it appears that myasthenia gravis primarily affects the sphincter rather than the dilator muscle. This may be related to the differences in innervation to the two muscles; the sphincter is predominantly innervated by cholinergic nerves while the dilator is predominantly innervated by adrenergic nerves (Lowenstein and Loewenfeld, I969) .
Defective accommodation has also been reported in patients with myasthenia gravis, because the ciliary muscle, too, is innervated by cholinergic nerve fibres (Manson and Stern, I965).
Clinically evident pupillary abnormalities including anisocoria, and sluggish or fatiguable pupillary responses to light have occasionally been reported (Fambrough, Drachman, and Satyamurti, 1973; Satyamurti, Drachman, and Slone, 1975) . It is of interest that topical administration of tropicamide, which acts by binding the cholinergic smooth muscle receptor sites blocking the action of acetylcholine, reduces AP, MRC, Ac, and Ad without clear mydriasis in normal subjects (Morgan and Analyses of the pupillary responses showed reduced amplitude, maximal velocity, and maximal acceleration of pupillary constriction in the myasthenic patients. On the other hand, changes in parameters of pupillary dilatation were minimal. Abnormal values returned towards normal within five minutes after edrophonium injection in all patients except in one individual who was being treated with corticosteroids at the time of examination. These results suggest that involvement of the iris sphincter may be common in patients with myasthenia gravis and this can be demonstrated by analysing the pupillary reaction and its derivative curves in response to an open-loop stimulus. 
